Key Record Dates
ClinicalTrials.gov Identifier: | NCT03755518 |
---|---|
Brief Title: | A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM) |
First Submitted : | November 8, 2018 |
First Submitted that Met QC Criteria : | November 26, 2018 |
First Posted : | November 28, 2018 |
Results First Submitted : | November 22, 2022 |
Results First Posted with QC Comments : | December 20, 2022 |
Results First Submitted that Met QC Criteria : | February 13, 2023 |
Results First Posted : | March 9, 2023 |
Last Update Submitted that Met QC Criteria : | February 13, 2023 |
Last Update Posted : | March 9, 2023 |